Cyclacel Pharmaceuticals Preferred Stock Probability of Future Preferred Stock Price Finishing Over 5.80
| CYCCP Preferred Stock | USD 5.80 0.04 0.69% |
Cyclacel |
Cyclacel Pharmaceuticals Target Price Odds to finish over 5.80
The tendency of Cyclacel Preferred Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 5.80 | 90 days | 5.80 | close to 99 |
Based on a normal probability distribution, the odds of Cyclacel Pharmaceuticals to move above the current price in 90 days from now is close to 99 (This Cyclacel Pharmaceuticals probability density function shows the probability of Cyclacel Preferred Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Cyclacel Pharmaceuticals has a beta of -0.46 suggesting as returns on the benchmark increase, returns on holding Cyclacel Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Cyclacel Pharmaceuticals is likely to outperform the market. Additionally Cyclacel Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Cyclacel Pharmaceuticals Price Density |
| Price |
Predictive Modules for Cyclacel Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cyclacel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the preferred stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the preferred stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cyclacel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cyclacel Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cyclacel Pharmaceuticals is not an exception. The market had few large corrections towards the Cyclacel Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cyclacel Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cyclacel Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.33 | |
β | Beta against Dow Jones | -0.46 | |
σ | Overall volatility | 0.47 | |
Ir | Information ratio | -0.11 |
Cyclacel Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cyclacel Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cyclacel Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cyclacel Pharmaceuticals generated a negative expected return over the last 90 days | |
| Cyclacel Pharmaceuticals has high historical volatility and very poor performance | |
| Cyclacel Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (18.89 M) with loss before overhead, payroll, taxes, and interest of (338 K). | |
| Cyclacel Pharmaceuticals has accumulated about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32. |
Cyclacel Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cyclacel Preferred Stock often depends not only on the future outlook of the current and potential Cyclacel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cyclacel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 36.6 M |
Cyclacel Pharmaceuticals Technical Analysis
Cyclacel Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Cyclacel Preferred Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cyclacel Pharmaceuticals. In general, you should focus on analyzing Cyclacel Preferred Stock price patterns and their correlations with different microeconomic environments and drivers.
Cyclacel Pharmaceuticals Predictive Forecast Models
Cyclacel Pharmaceuticals' time-series forecasting models is one of many Cyclacel Pharmaceuticals' preferred stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cyclacel Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the preferred stock market movement and maximize returns from investment trading.
Things to note about Cyclacel Pharmaceuticals
Checking the ongoing alerts about Cyclacel Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cyclacel Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cyclacel Pharmaceuticals generated a negative expected return over the last 90 days | |
| Cyclacel Pharmaceuticals has high historical volatility and very poor performance | |
| Cyclacel Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (18.89 M) with loss before overhead, payroll, taxes, and interest of (338 K). | |
| Cyclacel Pharmaceuticals has accumulated about 29.08 M in cash with (18.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.32. |
Additional Tools for Cyclacel Preferred Stock Analysis
When running Cyclacel Pharmaceuticals' price analysis, check to measure Cyclacel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclacel Pharmaceuticals is operating at the current time. Most of Cyclacel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cyclacel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclacel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cyclacel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.